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Abstract: Calcium phosphate (CaP) particles as a carrier in an
injectable bone filler allows less invasive treatment of bony
defects. The effect of changing granule size within a poloxamer
filler on the osteointegration of silicate-substituted calcium
phosphate (SiCaP) bone substitute materials was investigated
in an ovine critical-sized femoral condyle defect model. Treat-
ment group (TG) 1 consisted of SiCaP granules sized 1000–2000
lm in diameter (100 vol %). TG2 investigated a granule size of
250–500 lm (75 vol %), TG3 a granule size of 90–125 lm (75 vol
%) and TG4 a granule size of 90–125 lm (50 vol %). Following a
4 and 8 week in vivo period, bone area, bone-implant contact,
and remaining implant area were quantified within each defect.
At 4 weeks, significantly increased bone formation was meas-
ured in TG2 (13.32% 6 1.38%) when compared with all other
groups (p ¼ 0.021 in all cases). Bone in contact with the bone
substitute surface was also significantly higher in TG2. At 8
weeks most new bone was associated within defects containing
the smallest granule size investigated (at the lower volume)
(TG4) (42.78 6 3.36%) however this group was also associated
with higher amounts of fragmented SiCaP. These smaller par-
ticles were phagocytosed by macrophages and did not appear
to have a negative influence on healing. In conclusion, SiCaP
granules of 250–500 lm in size may be a more suitable scaffold
when used as an injectable bone filler and may be a convenient
method for treating bony defects. VC 2013 The Authors. Journal of
Biomedical Materials Research Part B: Applied Biomaterials Published
by Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater
101B: 902–910, 2013.
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INTRODUCTION
Silicate-substituted calcium phosphate has been used clinically
in place of autograft and allograft and reported to further aug-
ment bone formation when compared with stoichiometric
hydroxyapatite (HA).1 The purpose of a bone graft substitute
material is to enhance bony regeneration within the defect
area. This new bone should ideally penetrate and replace the
graft through sequential remodelling, enabling the repair site
to maintain an optimal balance between form, and function.2
A limitation with current CaP bone substitute materials is that
they exist in a large granular form, limiting it’s handling ability
during surgery.3 Recently, injectable and moldable forms of
bone substitute material have been developed as they offer
many advantages including increased handling ability during
surgery and due to their ability to completely ﬁll contained
defects of complex geometric shapes.4 In addition, with the
development of minimally invasive surgical methods, directly
injectable biomaterials are required.
The mechanisms behind bone’s response to CaP have
not yet been fully established however a number of studies
have demonstrated that osteointegration, osteoinduction,
and osteoconduction are inﬂuenced by morphology, crystal-
linity, porosity, surface roughness, chemistry, and calcium to
phosphate ratio.5–7 Granule size is also thought to be impor-
tant as it has an effect on the rate of resorption and the
ability of the material to promote bone growth.8 Previous
studies have shown that a minimum space of 100 lm
between graft particles is essential to allow for neo-vascu-
larisation and bone formation and that when the spaces
become larger, bone growth increases.9–11 Particle sizes of
about 380 lm in diameter will yield this minimal dimension
of inter-particular space.12 A study by Yukna et al.11
reported that particle sizes between 300 and 500 lm
provided adequate space between the particles and were
optimum for the treatment of periodontal bone defects,
however a study by Felipe et al.10 found that bioglass
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particles of smaller size range underwent faster resorption
and were subsequently replaced by more new bone also
shown in canine periodontal defects. Oonishi et al.13 eval-
uated the osteointegration of HA granules of 1–3 lm, 10 lm,
and 100–300 lm in diameter and reported that a minimal
size of 10 lm was necessary for direct bone contact between
bone and the HA granules. A study by Kuroda et al.14 investi-
gated bone defects ﬁlled with HA granules of varying sizes.
They reported improved osteoconductive activity in the
group with granules 100–300 lm in size when compared
with larger sized particles of 1–2 mm. Sun et al.15 also investi-
gated the effect of varying sizes of HA granules (from 0.5 to
841 lm) in osteoblast cultures and reported inhibitory effects
for sizes ranging from 0.5 to 3 lm.
The aim of this study was to investigate injectable sili-
cate-substituted calcium phosphate bone substitute materials
and the inﬂuence of granule size on the regeneration of bone
within cancellous critical-sized defects in an ovine model. We
hypothesised that small particles of SiCaP implanted in a
poloxamer paste would provide a larger surface area thereby
inducing more bone formation both in direct contact with the
SiCaP surface and within the spaces in between.
MATERIALS AND METHOD
Thirty-two implants were inserted into one of four cylindrical
critical-sized defects created in the medial femoral condyle of
10 skeletally mature female commercially cross-bred sheep
weighing between 65 and 80 kg and aged between 2 and 5
years. Positions were rotated such that no implant was placed
in the same location in each sheep more than once. Repeats of
four implants in each group at both 4 and 8 weeks were inves-
tigated. All procedures were carried out following Ethics ap-
proval granted by the Royal Veterinary College and in compli-
ance with United Kingdom Home Ofﬁce regulations [Animal
Scientiﬁc Procedures Act (1986)]. Porous ceramic foams with
varied strut porosity were manufactured via a foaming route
where ceramic slurries comprising SiCaP powders, polyvinyl
alcohol, and double distilled water were mechanically foamed
in a ball mill. The resulting foamed slip was then cast into a
mould and dried in air at a temperature of 40–50C for up to
48 h. The dried green castings were then sintered at tempera-
tures of 1200–1300C for 2 h. The sintered porous monoliths
were removed from the sintering furnaces and mechanically
crushed between two ceramic-coated paddles. The sintered
material was subsequently crushed and sieved to make irregu-
lar granules of different size that were of exactly the same
chemistry and morphology. Therefore SiCaP scaffolds in each
experimental group were identical and differed only in the size
of granules produced. Prior to insertion, each of the granules
in TG2, TG3, and TG4 were combined with poloxamer 407 to
allow easier handling of the granules and to prevent their
migration out of the defect. In TG1, a volume of 100% granules
(no carrier) was inserted into defects. All granules were sup-
plied by ApaTech, (Centennial Park, Elstree, UK). The four
treatment groups investigated are shown in Table I.
The silicate-substituted calcium phosphate (substituted
with 2.6 wt % silicate or 0.8 wt % Si) used in this study was
phase-pure with a total macroporosity of 80% and a micro-
porosity of 10%. The average pore diameter of the macro-
pores was 300 lm, and micropore diameter within the strut
porosity was less than 50 lm where pores typically ranged
between 1 and 10 lm. The volume of closed strut pores was
<10%. Phase purity of the materials was conﬁrmed by X-ray
diffraction (XRD) as described previously.16 The calcium,
phosphorus, and silicon contents were determined by X-ray
ﬂuorescence (XRF) also as previously described.16
Surgery
Animals were placed in ventral recumbence and an incision
3 cm in length made over the right femoral condyle. The
muscle was exposed and parted by blunt dissection and two
critical size 8  15 mm2 holes made.17 Following irrigation,
the appropriate test material was applied using a syringe and
gently pressed into place. In TG1, granules were gently
poured into the defect. The wound was then closed. Sites
were allocated to treatment group and test materials rotated
between animals such that no animal had two test materials
of the same type. This procedure was repeated on the contra-
lateral side resulting in a total of four implants inserted in
each animal. Following surgery, animals were allowed imme-
diate postoperative mobilisation as tolerated. Antibiotic and
analgesic prophylaxis was administered daily with subcutane-
ous injections of Baytril (Enroﬂoxacin 5 mg/kg; Bayer AG
Leverkusen) and Finadyne (Flunixin Meglumine 2 mg/45 kg;
Schering-Plough) for 3 days post-surgery. Animals were kept
in individual pens for 1 week post operatively before being
group housed. Implants remained in vivo for 4 and 8 weeks.
Histological analysis
On retrieval, condyles were immediately placed in 4% para-
formaldehyde solution for 3 days before being processed for
undecalciﬁed histology. After dehydration in alcohol and
defatting in chloroform, specimens were embedded in hard
grade acrylic resin (LR White, London Resin Company, Read-
ing, UK) following dehydration in serial dilutions of alcohol.
A longitudinal thin section (60 lm thick) was prepared
through the centre of each defect using grinding and polish-
ing techniques (EXAKT, Norderstedt, Germany) and sections
stained with Toluidine Blue and Paragon respectively. A
total of 8 images of each defect were captured using a 5
objective lens onto the image analysis system (Axiovision
4.5; Carl Zeiss, Jena, Germany) (Figure 1). The line intercept
method was used and a mask of interconnecting lines meas-
uring 10 x 12 mm was placed over the image and the type
of material (mineralised bone, soft tissue or implant
TABLE I. A Table Showing Details of the Four Treatment
Groups Investigated
Test
Material Abbrev.
Volume of
granules in
Poloxamer 407
SiCaP
Granule
Size (lm)
Treatment Group 1 TG1 100% (no carrier) 1000–2000
Treatment Group 2 TG2 75% 250–500
Treatment Group 3 TG3 75% 90–125
Treatment Group 4 TG4 50% 90–125
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material) at the intersection of each line was determined
(total 225 intercept points per image). Assessments were
used to evaluate the proportion of mineralised bone formed,
soft tissue and implant material within each defect and at
each of the 8 regions. For bone-implant contact, the type of
tissue at the interface was determined at the points where
lines intersected with the CaP biomaterial surface. Quantiﬁ-
cation of bone in pores > 20 lm were measured. Bone in
pores < 20 lm were not measured as these sized pores
occurred predominantly within the struts of the scaffold.
Data was quantiﬁed and compared between groups.
Scanning electron microscopy
Thin sections were sputter-coated with a layer of gold palladium
and viewed using backscattered Scanning Electron Microscopy
(JSM-35C; Jeol, Welwyn Garden City, United Kingdom).
Statistics
All data collected from the study was input into a statistical
software package (version 10.1; SPSS, Chicago, IL) for analy-
sis. A Kolmogorov-Smirnov test showed that all data was
nonparametric and a Mann Whitney U test was used to
compare results obtained in the different experimental
groups; p values < 0.05 were considered signiﬁcant. Mean
values are presented with standard error of mean.
RESULTS (4 WEEKS)
New bone formation
At 4 weeks results showed new bone formation within
defects in all experimental groups. Highest bone values
were measured in the TG2 group (13.32 6 1.38%) when
compared with TG3: 1.00 6 0.16%; p ¼ 0.021) and TG4:
3.28 6 0.53%; p ¼ 0.021). No signiﬁcant difference was
observed when TG2 data was compared with TG1 (7.64 6
2.67%) [Figure 2(A)]. Signiﬁcantly increased bone was
measured in TG4 when compared with TG3 specimens (p ¼
0.021) and no signiﬁcant difference was found when TG1
and TG3 were compared.
Bone-implant contact
Bone contact results showed that signiﬁcantly increased
contact values were found in TG2 (35.49 6 6.03%) when
compared with TG3 (1.75 6 0.54%; p ¼ 0.021) and TG4
(6.63 6 1.15%; p ¼ 0.021). No signiﬁcant difference was
found when this group was compared with TG1 (26.37 6
7.17%). Signiﬁcantly increased bone contact was seen in
TG1 when compared with both TG3 (p ¼ 0.021) and TG4
(p ¼ 0.043). Signiﬁcantly increased contact was measured
in the TG4 group when compared with TG3 (p ¼ 0.021)
[Figure 2(B)].
FIGURE 1. A diagram of a defect showing how the regions were
divided for analysis.
FIGURE 2. A Graph Comparing Bone area, contact and scaffold area
in Defects at 4 Weeks post surgery: A) Bone area; B) Bone contact
and C) Scaffold area (*p<0.05).
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Remaining implant area
Results showed signiﬁcantly increased amounts of SiCaP
present in TG3 defects (65.93 6 1.88%) when compared
with both TG2 (27.54 6 2.07%; p ¼ 0.021) and TG1 (38.89
6 2.87%; p ¼ 0.021). There was no signiﬁcant difference in
the amount of SiCaP present when TG3 and TG4 (44.12 6
12.81%) were compared and when TG4 defects were com-
pared with TG1 [Figure 2(C)].
RESULTS (8 WEEKS)
New bone formation
Results at 8 weeks showed that total bone area had signiﬁ-
cantly increased within defects in all groups investigated
when compared with the 4-week time point (p ¼ 0.021 in
all cases). At 8 weeks, the highest increase in bone was
measured in TG4 (42.78 6 3.36%) and lowest in TG3
(30.36 6 3.49%) (TG1: 34.95 6 1.73%; TG2: 36.50 6
2.30%). Results showed no signiﬁcant differences between
groups except when TG3 and TG4 specimens were com-
pared (p ¼ 0.043) [Figure 3(A)].
Bone-implant contact
Percentage bone contact also signiﬁcantly increased at this
time point when compared with the 4 week data in all
groups (p ¼ 0.021 in all cases). At 8 weeks, highest values
were measured in TG1 (72.63 6 3.51%) and lowest in TG3
specimens (30.87 6 6.15%) (TG2: 67.09 6 4.66%; TG4:
66.54 6 6.74%). Signiﬁcantly increased bone contact was
seen in all groups when compared with TG3 (p ¼ 0.021 in
all cases) [Figure 3(B)]. No other signiﬁcant differences
between groups were identiﬁed.
Remaining implant area
In all groups the amount of SiCaP scaffold present within
the defect had decreased when compared with data
obtained 4 weeks post surgery, however a signiﬁcant
decrease was seen only within TG1 (29.89 6 1.48%) (p ¼
0.021) and TG3 (36.15 6 8.27%) defects (p ¼ 0.021).
Results showed that signiﬁcantly more scaffold was present
in TG1 when compared with TG2 (23.00 6 1.55%) (p ¼
0.043) and signiﬁcantly increased SiCaP was present in TG4
(31.22 6 2.62%) when compared with TG2 defects (p ¼
0.043) [Figure 3(C)]. No other signiﬁcant differences were
found at this time point. The largest implant resorption rate
was measured in the TG3 group with a loss of 45.17% of
scaffold over the 4-week period. The amount of SiCaP pres-
ent in TG1 had decreased by 23.14%, TG2 by 16.49%, and
TG4 by 29.24%.
Light and backscattered electron microscopy
At 4 weeks post surgery and in all experimental groups, a
trend was seen where areas within the proximal aspect of
the defect and regions close to the periphery showed
increased new bone formation when compared with regions
located within the centre of the defect. In areas close to the
periphery, some granules were surrounded by bone how-
ever few areas of new bone formation were observed within
the centre of the defect. In all groups bone formation
appeared to occur by direct intra-membranous ossiﬁcation
without the formation of chondroid tissue. Osteoblasts were
seen actively depositing bone (Figure 4). In all groups, bone
appeared to be ‘‘conducted" along the surface of the implant
and in many places new bone had bridged SiCaP granules
together. Areas of vascular invasion were observed within
soft tissue and throughout the defect in all groups. In TG2,
SiCaP granules were notably smaller when compared with
TG1 and notably larger when compared with TG3 and TG4
(Figures 5 and 6). Due to the smaller size of the granules in
the TG3 and TG4 groups, graft within the defects appeared
more evenly distributed and more densely packed. In addi-
tion and in these two groups, light microscopy showed thick
FIGURE 3. A Graph Comparing Bone area, contact and scaffold area
in Defects at 8 weeks post surgery: A, Bone area; B, Bone contact; C,
scaffold area (*p < 0.05).
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basinophylic collagen ﬁbres branching between the SiCaP
granules forming a network onto which intramembraneous
bone formed (Figure 7). At 8 weeks and in all groups, the
majority of granules throughout each defect were in direct
contact with and surrounded by mature lamellar bone (Fig-
ure 8). Bone formation was seen both within the macro and
strut porosity. As particle size decreased, the amount of par-
ticulate ceramic debris increased and these areas were
encapsulated by soft tissue. Macrophages were observed
phagocytosing particulate debris however, their presence
did not seem to have an adverse effect on bone growth and
in many instances, osteoblasts could be seen actively depos-
iting osteoid immediately adjacent to particulate SiCaP.
In all groups at 4 weeks, backscattered scanning elec-
tron microscopy showed new bone formation within the
defects with most bone growing preferentially along the
surface of SiCaP granules and in some cases, especially in
regions close to the periphery, bridging granules together.
Large proportions of the central defect in all groups were
devoid of bone at 4 weeks. SEM also showed the difference
in granule size between groups (Figure 9). In places where
bone formation had occurred, bone made contact with the
outer surface of granules and also at times, within the pore
FIGURE 4. Osteogenesis at the surface of SiCaP granules in TG3 located
at the centre of the defect 4 weeks post-implantation (Mag. 20).
FIGURE 5. New bone growth at 4 weeks post surgery within TG1 and
at region close to the periphery of the defect (Mag. 5).
FIGURE 6. (a,b) A low-powered image of densely packed TG4 gran-
ules at a region close to the bottom of the defect showing intergranu-
lar bone formation despite tight packing at 4 weeks (Mag. fig a: 5;
fig b: 2.5).
FIGURE 7. At 4 weeks collagen fibres branch between packed TG4
granules onto which bone is directly deposited. (Mag. 2.5).
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FIGURE 8. A: A montage of SEM images through the defect of a TG2 specimen in the anterior/posterior direction at 4 weeks. B: A montage of
SEM images through the defect of a TG3 specimen in the anterior/posterior direction at 4 weeks. In comparison to (A), the particle size is notably
smaller. C: A montage of SEM images through the defect of a TG2 specimen in the anterior/posterior direction at 8 weeks.
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structure. In all groups at 8 weeks, scanning electron mi-
croscopy showed mature lamellar bone surrounding SiCaP
granules with extensive bone growth throughout the
defects. In many instances and in all groups, Haversian sys-
tems lay adjacent the graft material. In two dimensions it
was evident that bone was able to use the SiCaP as a scaf-
fold to bridge bone within the defect. In both TG1 and TG2
packed defects isolated SiCaP granules were not seen and
all were in contact through a bone bridge with others. How-
ever in both TG3 and TG4, isolated granules (some of which
were surrounded by bone) were evident. Bone was in con-
tact with the outer SiCaP surface and within the micro-
porosity of the structure and also occurred in pores as small
as 20 lm. In TG3 and TG4 at 8 weeks, bone formation was
less uniform than in the other groups and although bone
had bridged the entire defect, bone formation was greater
towards the walls adjacent to the host bone.
DISCUSSION
The aim of this study was to investigate the effect of gran-
ule size on the osteointegration of injectable silicate-substi-
tuted calcium phosphate in an ovine critical-sized femoral
condyle defect model. The repair of critical-sized bone
defects is challenging in the ﬁelds of maxillofacial and
orthopaedic surgery and current therapies such as auto-
grafts and allografts are associated with various limita-
tions.18–22 The repair rate of a bony defect is mainly
dependent on defect size and osteogenesis is associated
with migration of osteoblasts. Even in larger stable defects
the faster migrating ﬁbroblasts induce more ﬁbrous tissue
which becomes dominant in the bone defect.23 The critical-
sized bone defect is deﬁned as the smallest size intraoss-
eous wound that will not spontaneously heal completely
with bone tissue.23 In the ovine model this size is 8  15
mm2 and these defects are well suited for the placement of
materials for the evaluation of the bone healing response to
bone substitutes.17
In our study, four experimental groups containing sili-
cate-substituted calcium phosphate of different granule size
were investigated. Qualitative analysis using light microscopy
identiﬁed new bone formation in all groups at both the 4-
and 8-week time-points. In addition, no poloxamer carrier
was identiﬁed in any of the defects at either time point. Light
microscopy also showed good vascularisation in all groups
with blood vessels evident both adjacent to granules and
within the macro pores of the scaffold. No obvious differen-
ces were seen in the amount of vascularisation within any of
the groups. Many areas of osteogenesis were seen adjacent
to the granules with osteoblasts observed actively laying
down bone. Light microscopy also identiﬁed collagen ﬁbres
in between granules onto which osteoid was deposited and
subsequently mineralised. At both the 4 and 8-week time
point, osteogenesis occurred both within the macropores and
adjacent to the scaffold surface with no evidence of cartilage
matrix deposition in any of the groups. Even with small gran-
ules bone formation occurred even though the number of
macropores was reduced. This implies that macropore struc-
ture is not necessary for bone formation. A number of
articles have indicated that porous bone graft substitute
materials form bone preferentially on the concave surface of
the pore.24–26 However, in our study due to the small size of
the granules, the porous structure was reduced but bone
formation still occurred indicating that macropores are not
necessary provided an appropriate packing density between
granules that allows bone formation.
A study by Oreffo et al.27 showed that newly differenti-
ated osteoprogenitor cells are more important and known to
make a major contribution to bone defect ﬁlling and tissue
repair when compared with pre-existing osteoblasts. A study
by Weibenbock et al.28 investigated the cellular response of
human mesenchymal stem cells (hMSC’s) on HA of different
particle size in vitro and showed that hMSCs cultured on par-
ticles smaller than 100 lm showed highest cell viability and
highest levels of alkaline phosphatase release. However, gran-
ule size had no signiﬁcant effects on the up-regulation of
osteocalcin and osteopontin in these cells. They concluded
that substrate signals have a substantial effect on the pheno-
typic characteristics of a multipotent cell type, even in the
presence of strong osteogenic inductive signals, and that the
physical size of the biomaterial carrier may be crucial in the
repair of tissues. However, studies have also shown that HA
debris can cause inﬂammatory reactions and that small par-
ticles of HA (<20 lm) with an irregular geometry were
reported to possess a cytotoxic potential by inducing strong
inﬂammatory reactions compared with larger sized particles
>20 lm.15 An in vitro study by Evans et al.29 measured an
FIGURE 9. TG3 implant at 8 weeks duration showing soft tissue (S)
enclosing defect site without any evidence of inflammation. The
defect site is a mixture of bone and SiCaP granules distributed evenly
throughout the site.
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increase in the ﬁbroblast mitotic rate in the presence of syn-
thetic HA particles between 3.7 and 99 lm. An in vivo study
by Oonishi et al.13 demonstrated that particles larger than 10
lm were required for successful bone augmentation. In our
study and 8 weeks post surgery, increased bone was meas-
ured in defects adjacent to granules 90 – 125 lm in size
however fragmentation of SiCaP (< 20 lm) was also evident
in this smallest sized granule group (TG3 and 4). Less frag-
mentation was observed in the largest granule group (TG1).
Where areas of fragmentation were seen, bone did not grow
and particles were instead encapsulated within soft tissue. In
localised regions particles were engulfed by macrophages,
however SiCaP fragmentation did not impede new bone
formation as osteoblasts were seen depositing bone immedi-
ately adjacent to particulate debris.
The bioactivity of calcium phosphate materials is believed
to be associated with material dissolution and the release of
calcium and phosphate ions from the implant surface followed
by the precipitation of a biological apatite layer.30 Conse-
quently it is thought that the surface rapidly absorbs more
proteins and promotes the adhesion of osteoblasts in particu-
lar.31 Decreasing the size of the granules resulted in more
space for granules and increased SiCaP surface area within
the defect. This larger surface area may have provided an
increase in dissolution of Ca and P ions leading to greater
apatite deposition and more protein adsorption, osteoblast ad-
hesion and increased bone growth.28 Resorption of the scaf-
fold has a large inﬂuence on bone-bonding properties and the
degradation characteristics of CaPs are governed by the chem-
ical composition, crystal structure, crystal and grain size,
microporosity, neck geometry, and neck dissolution rates of
the material.13 In our study, the SiCaP investigated was identi-
cal in composition and manufacture and granule size was the
only variable investigated. A study by Felipe et al.10 showed
distinct dissolution rates for Bioglass of different size ranges.
Results from the study reported a statistically signiﬁcant dif-
ference favouring bone growth adjacent to granules 300–355
lm in size when compared with those of 90–710 lm in size.
Bioglass particles of smaller size underwent faster resorption
and substitution by new bone than did granules with a larger
variation in size. A study by Shapoff et al.8 in monkey femurs,
reported that granules of 100–300 lm resulted in signiﬁcantly
increased bone formation when compared with growth adja-
cent to 1000–2000 lm sized granules. Hall et al.32 compared
Bioglass granules with small and large size ranges showing no
signiﬁcant difference in the amount of bone formed and in
contact with the material surface after 4 months in the treat-
ment of intrabony defects in the canine mandible. Results
obtained by Hall et al. led Felipe et al. to speculate and
conclude in their study that granule size may not affect bony
formation during longer healing periods (>3 months) how-
ever, granules of a small size range leads to more rapid
resorption and more rapid new bone formation at early time
points following surgery. This is in contrast to results obtained
in our study which showed that the smaller granules did not
induce more rapid bone regeneration within the defect at 4
weeks when compared with the larger granules investigated.
In addition, our study also demonstrated that the group
showing highest amount of implant resorption over the 4–8
week time point [TG3 (45.17%)] also demonstrated least
amounts of bone formation and bone-implant contact at
8 weeks when compared with all other groups.
A study by Fischer et al.33 investigated hydroxyapatite
granules of varying size (212–300 lm and 500–706 lm)
both in vitro and in vivo and reported abundant de novo
bone formation adjacent to granule size 212–300 lm,
whereas particles with a diameter of 500–706 lm showed no
bone formation. This study concluded that not only is granule
size important for bone formation to occur but also the
three-dimensional architecture and microenvironment cre-
ated by packing of the granules. Fischer et al. suggest that
this 3D environment created by the packing of the granules
provides a macroporosity and free space for invasion by
body ﬂuids, nutrients, host cell and blood vessels and that
differences in bone formation in HA granules of different size
may be linked to granule packing and that granules 500–706
lm in size created a macroporosity that was unfavorable for
bone formation. Previous studies have demonstrated the sig-
niﬁcant effect that inter-granular space has on bone forma-
tion.6,7 Our study did not quantify the packing spaces gener-
ated, but nevertheless osteogenesis was identiﬁed within the
granular spaces in all groups. It is estimated that the inter-
granular space was least in TG3 specimens (range 10–300
lm with an average of 50 lm between granules) as the
smaller granules were packed together more tightly within
the defect and largest in TG1 (range 100–300 lm with an
average of 100 lm). It is also possible that the inter-granu-
lar space increased over time as the implant resorbed
thereby inﬂuencing the degree and extent of bone formation
within the different granules sizes. Qualitative observation
showed a reduction in granule size however the shape of
granules appeared to remain the same over the 8-week pe-
riod. Further work is necessary to investigate the effect of
inter-granular space. Nevertheless, results from our study
showed that speed of bone growth was initially more rapid
adjacent to larger particles however at a later stage, the
smallest granules induced more bone formation. Clearly from
our study there are a number of factors that affect bone for-
mation and it appears that the size and packing density
between granules is an important parameter.
CONCLUSIONS
The options for bone grafts used clinically are numerous
and this study aimed to improve our knowledge of the biol-
ogy and physiology that controls bone formation within
SiCaP scaffolds. Although TG1 contained no polaxomer car-
rier, this group was included in this study as it represented
graft material that is used clinically and therefore acted as
control to our experimental groups. The results of this study
showed that all grafts investigated are potentially suitable
as a bone graft substitute material and at 8 weeks the
smallest granule size encouraged increased amounts of
bone within the defect. However, this study also showed
that these small granules were also associated with higher
amounts of SiCaP fragmentation and while they did not
appear to have a negative inﬂuence on healing and bone
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formation, they may take up valuable space in which new
bone could grow. Therefore, for more beneﬁcial long-term
results, particles sized 250–500 lm may be most advanta-
geous to use. The SiCaP granules used in this study in com-
bination with a poloxamer paste allows the injection of
granules into defects which is able to induce bone formation
rapidly and is an important option for the application of
bone graft substitutes.
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